Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Linton Peters

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Oncologist|May 22, 2020
In ReplyInbar Raber, Mary Linton Peters, Aarti Asnani
BMJ Case Reports|May 2, 2024
Efficacy of dual checkpoint inhibitors in a patient with a mixed hepatocellular cholangiocarcinomaSantiago Sucre, Andrea Bullock, Mary Linton Peters
Gynecologic Oncology|April 30, 2017
Managing hereditary breast cancer risk in women with and without ovarian cancerMary Linton Peters, Judy E Garber, Nadine Tung
BMJ Case Reports|February 6, 2023
Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumabRodrigo Paredes de la Fuente, James W Doolin, Mary Linton Peters
Case Reports in Oncology|July 17, 2024
Cancer of Unknown Primary: When Imaging, Pathology, and Molecular Biology Do Not MatchJuan Jose Juarez-Vignon Whaley, Prateek Pophali, Yevgen Chornenkyy, et al.
JCO Precision Oncology|May 29, 2025
PD-L1 Expression in Biliary Tract Cancer: Comparison Across Antibody Clones and Role as a Predictor of Response to Chemoimmunotherapy: A Meta-AnalysisJuan J Juarez-Vignon Whaley, Soravis Osataphan, Ben Ponvilawan, et al.
Stereotactic and Functional Neurosurgery|December 23, 2011
Changing practice patterns of deep brain stimulation in Parkinson's disease and essential tremor in the USAJulie G Pilitsis, Anthony Burrows, Mary Linton Peters, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
Burden of illness for patients with cholangiocarcinoma in the United States: a retrospective claims analysisChristina X Chamberlain, Elizabeth Faust, Debbie Goldschmidt, et al.
JCO Precision Oncology|July 10, 2025
Prognostic Role of <i>MTAP</i> Loss in CholangiocarcinomaJames Lyon, Soravis Osataphan, Vaibhav Birda, et al.
The Oncologist|March 13, 2020
Fluoropyrimidine-Associated Cardiotoxicity: A Retrospective Case-Control StudyInbar Raber, Sarah Warack, Jaya Kanduri, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Oncologist|May 22, 2020
In ReplyInbar Raber, Mary Linton Peters, Aarti Asnani
BMJ Case Reports|May 2, 2024
Efficacy of dual checkpoint inhibitors in a patient with a mixed hepatocellular cholangiocarcinomaSantiago Sucre, Andrea Bullock, Mary Linton Peters
Gynecologic Oncology|April 30, 2017
Managing hereditary breast cancer risk in women with and without ovarian cancerMary Linton Peters, Judy E Garber, Nadine Tung
BMJ Case Reports|February 6, 2023
Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumabRodrigo Paredes de la Fuente, James W Doolin, Mary Linton Peters
Case Reports in Oncology|July 17, 2024
Cancer of Unknown Primary: When Imaging, Pathology, and Molecular Biology Do Not MatchJuan Jose Juarez-Vignon Whaley, Prateek Pophali, Yevgen Chornenkyy, et al.
JCO Precision Oncology|May 29, 2025
PD-L1 Expression in Biliary Tract Cancer: Comparison Across Antibody Clones and Role as a Predictor of Response to Chemoimmunotherapy: A Meta-AnalysisJuan J Juarez-Vignon Whaley, Soravis Osataphan, Ben Ponvilawan, et al.
Stereotactic and Functional Neurosurgery|December 23, 2011
Changing practice patterns of deep brain stimulation in Parkinson's disease and essential tremor in the USAJulie G Pilitsis, Anthony Burrows, Mary Linton Peters, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
Burden of illness for patients with cholangiocarcinoma in the United States: a retrospective claims analysisChristina X Chamberlain, Elizabeth Faust, Debbie Goldschmidt, et al.
JCO Precision Oncology|July 10, 2025
Prognostic Role of <i>MTAP</i> Loss in CholangiocarcinomaJames Lyon, Soravis Osataphan, Vaibhav Birda, et al.
The Oncologist|March 13, 2020
Fluoropyrimidine-Associated Cardiotoxicity: A Retrospective Case-Control StudyInbar Raber, Sarah Warack, Jaya Kanduri, et al.
Pageof 2